Home › SALIX PHARMACEUTICALS, LTD. › Deflux®
Deflux®
SALIX PHARMACEUTICALS, LTD. · Model 1092203 · UDI-DI 00365649922039
LNM
Prescription
0
510(k) clearances
1,173
Adverse events (8 deaths)
3
Recalls
18
Facilities
Description
Deflux® is a bulking agent indicated for treatment of children with vesicoureteral reflux (VUR) grades II-IV.
Recalls
| Date | Firm | Reason |
|---|---|---|
| 2021-06-03 | Axonics Modulation Technologies, Inc. | Lack of Sterility Assurance; needle in procedure pack labeled as sterile may not have been adequately sterilized |
| 2020-09-30 | Merz North America, Inc. | The Instructions for Use (IFU) updated 03/02/2020 does not match data listed in the post-approval study. |
| 2005-09-23 | Boston Scientific Corporation | Incorrect implantation may cause serious health complications |
Query this across every FDA database — by API.
Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.
Get your free API keyRead the docsData compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.